Robert Molander

Robert Molander discloses dealings in XSpray Pharma AK to Finansinspektionen. Between 28 February 2023 and 20 November 2024, the trades on record add up to 4 filings.

Both buying and selling appear: 3 purchases worth €52k, against 1 sale worth €112. Taken together, the purchases exceed the sales by €52k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2024 alone, the filings show 1 purchase and 1 sale.

A typical purchase (the median) is worth €19k. 1 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.

The newest entry dates from 21 November 2024: an open-market sale of €112, in XSpray Pharma AK. The clock since the last published purchase (5 March 2024) now reads 962 days. The median gap between a trade and its publication by Finansinspektionen is 1 day. For comparison, MAR article 19 gives managers three business days to notify a trade. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.